Research map: Reading the Signal: What Psychedelic Trials in Depression Still Can’t Tell Us
Back to the article
Papers in this map
Towards a proposal for assessment of blinding success in clinical trials: up‐to‐date review
· Jafar Kolahi · 2009 · 139 citations · Cited by this paper
Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed Studies
· 2026 · Related
Expectancy Effects, Failure of Blinding Integrity, and Placebo Response in Trials of Treatments for Psychiatric Disorders
· Nathan T. M. Huneke · 2025 · 59 citations · Cited by this paper
Journal of Clinical Psychopharmacology Updates
· 2026 · Related
Risk of bias assessments for blinding of participants and personnel in Cochrane reviews were frequently inadequate
· Ognjen Barčot · 2019 · 37 citations · Cited by this paper
Vortioxetine Related Hypertriglyceridemia in a Young Male
· 2026 · Related
Common challenges and suggestions for risk of bias tool development: a systematic review of methodological studies
· E. Tomlinson · 2024 · 29 citations · Cited by this paper
Sugarless Candy in Treatment-Resistant Clozapine-Induced Sialorrhea
· 2026 · Related
The Therapeutic Potential of Psychedelics for Treatment-resistant Depression
· Natia Horato · 2026 · 4 citations · Cited by this paper
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia
· 2026 · Related
Menorrhagia Associated With Extended-Release Methylphenidate in an Adult Woman
· 2026 · Related
Hypnopompic Hallucinations
· 2026 · Related
Amantadine as an Alternative to VMAT2 Inhibitors for Tardive Dyskinesia in Patients at Risk of Depression and Suicidality
· 2026 · Related
Escitalopram-Associated Myopericarditis in a Young Adult
· 2026 · Related
Are the 8 Finnish Deaths Explained by Agranulocytosis More Important than the Thousands of Suicide Deaths Associated with the Lack of Use of Clozapine? Reflections on Clozaphobia
· 2026 · Related
Source: OpenAlex (CC0)